{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T18:04:12Z","timestamp":1773165852430,"version":"3.50.1"},"reference-count":53,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.drugalcdep.2013.06.024","type":"journal-article","created":{"date-parts":[[2013,7,31]],"date-time":"2013-07-31T13:45:20Z","timestamp":1375278320000},"page":"376-382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["Methadone and buprenorphine-naloxone are effective in reducing illicit buprenorphine and other opioid use, and reducing HIV risk behavior\u2014Outcomes of a randomized trial"],"prefix":"10.1016","volume":"133","author":[{"given":"David","family":"Otiashvili","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gvantsa","family":"Piralishvili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zura","family":"Sikharulidze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Kamkamidze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Poole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George E.","family":"Woody","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2013.06.024_bib0005","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3109\/08039488.2010.531762","article-title":"Effectiveness of buprenorphine maintenance treatment as compared to a syringe exchange program among buprenorphine misusing opioid-dependent patients","volume":"65","author":"Aalto","year":"2011","journal-title":"Nord. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2013.06.024_bib0010","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1046\/j.1365-2362.2003.01218.x","article-title":"Controlled, randomized trial in maintenance treatment of intravenous buprenorphine dependence with naltrexone, methadone or buprenorphine: a novel study","volume":"33","author":"Ahmadi","year":"2003","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.drugalcdep.2013.06.024_bib0015","first-page":"23","article-title":"Treatment of intravenous buprenorphine dependence. A randomized open clinical trial","volume":"6","author":"Ahmadi","year":"2003","journal-title":"Ger. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2013.06.024_bib0020","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/09595230701829553","article-title":"Buprenorphine injection in Melbourne, Australia\u2013an update","volume":"27","author":"Aitken","year":"2008","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.drugalcdep.2013.06.024_bib0025","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.drugalcdep.2006.09.012","article-title":"Abuse liability of buprenorphine-naloxone tablets in untreated IV drug users","volume":"88","author":"Alho","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2013.06.024_bib0030","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1111\/j.1360-0443.2009.02660.x","article-title":"Interventions with injection drug users in Ukraine","volume":"104","author":"Booth","year":"2009","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2013.06.024_bib0035","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1007\/s10461-008-9359-3","article-title":"Stimulant injectors in Ukraine: the next wave of the epidemic?","volume":"12","author":"Booth","year":"2008","journal-title":"AIDS Behav."},{"key":"10.1016\/j.drugalcdep.2013.06.024_bib0040","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1080\/00952990802585406","article-title":"Lack of reduction in buprenorphine injection after introduction of co-formulated buprenorphine\/naloxone to the Malaysian market","volume":"35","author":"Bruce","year":"2009","journal-title":"Am. J. Drug Alcohol Abuse"},{"issue":"Suppl. 4","key":"10.1016\/j.drugalcdep.2013.06.024_bib0045","doi-asserted-by":"crossref","first-page":"S197","DOI":"10.1086\/508184","article-title":"Buprenorphine use: the international experience","volume":"43","author":"Carrieri","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2013.06.024_bib0050","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1007\/s11524-011-9571-8","article-title":"Unsafe injection and sexual risk behavior among injecting drug users in Georgia","volume":"88","author":"Chikovani","year":"2011","journal-title":"J. Urban Health"},{"key":"10.1016\/j.drugalcdep.2013.06.024_bib0055","doi-asserted-by":"crossref","first-page":"492","DOI":"10.47102\/annals-acadmedsg.V35N7p492","article-title":"Abuse of prescription buprenorphine, regulatory controls and the role of the primary physician","volume":"35","author":"Chua","year":"2006","journal-title":"Ann. Acad. Med. Singapore"},{"key":"10.1016\/j.drugalcdep.2013.06.024_bib0060","doi-asserted-by":"crossref","first-page":"302","DOI":"10.5055\/jom.2007.0018","article-title":"Use and misuse of buprenorphine in the management of opioid addiction","volume":"3","author":"Cicero","year":"2007","journal-title":"J. Opioid Manag."},{"key":"10.1016\/j.drugalcdep.2013.06.024_bib0065","series-title":"The State of Buprenorphine Treatment. Buprenorphine in the Treatment of Opioid Addiction: Reassessment 2010","author":"Clark","year":"2010"},{"key":"10.1016\/j.drugalcdep.2013.06.024_bib0070","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1124\/jpet.102.038141","article-title":"Self-administration of intravenous buprenorphine and the buprenorphine\/naloxone combination by recently detoxified heroin abusers","volume":"303","author":"Comer","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2013.06.024_bib0075","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1124\/jpet.105.090423","article-title":"Comparison of intravenous buprenorphine and methadone self-administration by recently detoxified heroin-dependent individuals","volume":"315","author":"Comer","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2013.06.024_bib0080","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/sj.npp.1301479","article-title":"Abuse liability of prescription opioids compared to heroin in morphine-maintained heroin abusers","volume":"33","author":"Comer","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2013.06.024_bib0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta11090","article-title":"Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation","volume":"11","author":"Connock","year":"2007","journal-title":"Health Technol. Assess"},{"key":"10.1016\/j.drugalcdep.2013.06.024_bib0090","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.drugalcdep.2011.09.029","article-title":"Illicit use of buprenorphine in a community sample of young adult non-medical users of pharmaceutical opioids","volume":"122","author":"Daniulaityte","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2013.06.024_bib0095","series-title":"2010 National Report to the EMCDDA","author":"Diaz-Gomez","year":"2010"},{"key":"10.1016\/j.drugalcdep.2013.06.024_bib0100","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/infdis\/jis677","article-title":"Transmission of hepatitis C virus among people who inject drugs: viral stability and association with drug preparation equipment","volume":"207","author":"Doerrbecker","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2013.06.024_bib0105","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0376-8716(03)00169-8","article-title":"Buprenorphine versus methadone maintenance: a cost-effectiveness analysis","volume":"71","author":"Doran","year":"2003","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2013.06.024_bib0110","series-title":"Buprenorphine \u2014 treatment, misuse and prescription practices","author":"EMCDDA","year":"2005"},{"key":"10.1016\/j.drugalcdep.2013.06.024_bib0115","series-title":"The State of the Drugs Problem In Europe","author":"EMCDDA","year":"2008"},{"key":"10.1016\/j.drugalcdep.2013.06.024_bib0120","series-title":"Drug Situation in Georgia \u2013 2003","author":"Gamkrelidze","year":"2004"},{"key":"10.1016\/j.drugalcdep.2013.06.024_bib0125","series-title":"Drug Situation in Georgia \u2013 2004","author":"Gamkrelidze","year":"2005"},{"key":"10.1016\/j.drugalcdep.2013.06.024_bib0130","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000104883","article-title":"Buprenorphine misuse among heroin and amphetamine users in Malmo, Sweden: purpose of misuse and route of administration","volume":"13","author":"Hakansson","year":"2007","journal-title":"Eur. Addict. Res."},{"key":"10.1016\/j.drugalcdep.2013.06.024_bib0135","series-title":"Overview of the Drug Situation in Georgia, 2012","author":"Javakhishvili","year":"2012"},{"key":"10.1016\/j.drugalcdep.2013.06.024_bib0140","first-page":"42","article-title":"Overview of the drug situation in Georgia","volume":"11","author":"Javakhishvili","year":"2011","journal-title":"Adictologie"},{"key":"10.1016\/j.drugalcdep.2013.06.024_bib0145","series-title":"Drug Situation in Georgia \u2013 2005","author":"Javakhishvili","year":"2006"},{"key":"10.1016\/j.drugalcdep.2013.06.024_bib0150","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1360-0443.2004.00958.x","article-title":"Buprenorphine diversion and injection in Melbourne, Australia: an emerging issue?","volume":"100","author":"Jenkinson","year":"2005","journal-title":"Addiction"},{"issue":"Suppl. 2","key":"10.1016\/j.drugalcdep.2013.06.024_bib0155","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/S0376-8716(03)00060-7","article-title":"Buprenorphine: how to use it right","volume":"70","author":"Johnson","year":"2003","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2013.06.024_bib0160","series-title":"Assessing the Costs of Medication-Assisted Treatment for HIV Prevention in Georgia","author":"Kirtadze","year":"2012"},{"key":"10.1016\/j.drugalcdep.2013.06.024_bib0165","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1477-7517-6-22","article-title":"Drug choice, spatial distribution, HIV risk, and HIV prevalence among injection drug users in St. Petersburg, Russia","volume":"6","author":"Kruse","year":"2009","journal-title":"Harm Reduct. J."},{"key":"10.1016\/j.drugalcdep.2013.06.024_bib0170","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0740-5472(92)90062-S","article-title":"The Fifth Edition of the Addiction Severity Index","volume":"9","author":"McLellan","year":"1992","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2013.06.024_bib0175","series-title":"Annual Report: The Czech Republic\u20132009 Drug Situation","author":"Mravcik","year":"2010"},{"key":"10.1016\/j.drugalcdep.2013.06.024_bib0185","series-title":"Australian Drug Trends 2006 Findings from the Illicit Drug Reporting System (IDRS)","author":"O\u2019Brien","year":"2006"},{"key":"10.1016\/j.drugalcdep.2013.06.024_bib0190","article-title":"Drug control in Georgia:drug testing and the reduction of drug use? The Beckley Foundation Drug Policy Program","volume":"15","author":"Otiashvili","year":"2008","journal-title":"Briefing Paper Oxford"},{"key":"10.1016\/j.drugalcdep.2013.06.024_bib0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000253858","article-title":"Why do the clients of Georgian needle exchange programmes inject buprenorphine?","volume":"16","author":"Otiashvili","year":"2010","journal-title":"Eur. Addict. Res."},{"key":"10.1016\/j.drugalcdep.2013.06.024_bib0200","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/clpt.1993.72","article-title":"Subjective and physiologic effects of intravenous buprenorphine in humans","volume":"53","author":"Pickworth","year":"1993","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.drugalcdep.2013.06.024_bib0205","series-title":"US RB Pharmaceuticals Announcement","author":"Reckitt Benckiser Group","year":"2012"},{"key":"10.1016\/j.drugalcdep.2013.06.024_bib0210","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.addbeh.2008.07.018","article-title":"Buprenorphine sniffing as a response to inadequate care in substituted patients: results from the Subazur survey in south-eastern France","volume":"33","author":"Roux","year":"2008","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2013.06.024_bib0215","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1747-597X-3-16","article-title":"A retrospective evaluation of patients switched from buprenorphine (Subutex) to the buprenorphine\/naloxone combination (Suboxone)","volume":"3","author":"Simojoki","year":"2008","journal-title":"Subst. Abuse Treat. Prev. Policy"},{"key":"10.1016\/j.drugalcdep.2013.06.024_bib0220","first-page":"58","article-title":"Very high-dose intravenous buprenorphine dependence: a case report","volume":"7","author":"Singh","year":"2004","journal-title":"Ger. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2013.06.024_bib0225","series-title":"Measuring Alcohol Consumption","article-title":"Timeline follow-back: a technique for assessing self-reported alcohol consumption","author":"Sobell","year":"1992"},{"key":"10.1016\/j.drugalcdep.2013.06.024_bib0230","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.annemergmed.2003.11.006","article-title":"Buprenorphine: a primer for emergency physicians","volume":"43","author":"Sporer","year":"2004","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.drugalcdep.2013.06.024_bib0235","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1093\/infdis\/jir650","article-title":"Hepatitis C transmission in injection drug users: could swabs be the main culprit?","volume":"204","author":"Thibault","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2013.06.024_bib0240","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1176\/appi.ajp.2011.11071121","article-title":"Naltrexone implant for the treatment of polydrug dependence: a randomized controlled trial","volume":"169","author":"Tiihonen","year":"2012","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2013.06.024_bib0245","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.drugalcdep.2012.07.002","article-title":"Twelve-year trend in treatment seeking for buprenorphine abuse in Finland","volume":"127","author":"Uosukainen","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2013.06.024_bib0250","series-title":"Buprenophine, Critical Questions Examined","author":"Verster","year":"2005"},{"key":"10.1016\/j.drugalcdep.2013.06.024_bib0255","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.drugalcdep.2010.03.014","article-title":"Injection of buprenorphine and buprenorphine\/naloxone tablets in Malaysia","volume":"111","author":"Vicknasingam","year":"2010","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2013.06.024_bib0260","doi-asserted-by":"crossref","first-page":"451","DOI":"10.47102\/annals-acadmedsg.V35N7p451","article-title":"Socio-demographic profile and help-seeking behaviour of buprenorphine abusers in Singapore","volume":"35","author":"Winslow","year":"2006","journal-title":"Ann. Acad. Med. Singapore"},{"key":"10.1016\/j.drugalcdep.2013.06.024_bib0265","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.drugpo.2007.03.002","article-title":"Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia","volume":"19","author":"Winstock","year":"2008","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2013.06.024_bib0270","first-page":"1187","article-title":"Comparing the subjective, psychomotor and physiological effects of intravenous buprenorphine and morphine in healthy volunteers","volume":"282","author":"Zacny","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871613002433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871613002433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T19:30:38Z","timestamp":1715801438000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871613002433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0376871613002433"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2013.06.024","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methadone and buprenorphine-naloxone are effective in reducing illicit buprenorphine and other opioid use, and reducing HIV risk behavior\u2014Outcomes of a randomized trial","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2013.06.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}